Research Article
Use of the Serum Level of Cholinesterase as a Prognostic Marker of Nonfatal Clinical Outcomes in Patients Hospitalized with Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Table 2
Characteristics of the patients in the NIV group and the non-NIV group.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
AE, acute exacerbation; CHD, coronary heart disease; NLR, neutrophil-to-lymphocyte ratio; RDW, red blood cell distribution width; PLR, platelet-to-lymphocyte ratio; PDW, platelet distribution width; BUN, blood urea nitrogen; CRP, C-reactive protein; OI, oxygenation index; pCO2, partial pressure of carbon dioxide; NIV, noninvasive ventilation; IMV, invasive mechanical ventilation; ICU, intensive care unit; DoHS, duration of hospital stay. |